Schwab v. Schwab UDRP Results in Reverse Domain Name Hijacking Decision
February 2, 2023
Edited by Margaret A. Esquenet
Illustrating the dangers of filing a UDRP complaint where the domain registrant’s name and the asserted trademark are identical, a recent Uniform Dispute Resolution Policy (“UDRP”) decision denied the complaint, with a two-panelist majority finding the complaint failed to establish two of the three UDRP elements.
Complainant Charles Schwab has offered financial services under its SCHWAB and SCHWAB-formative marks for almost four decades. Respondent Simon Schwab, claiming to be an entrepreneur who began providing loans to customers during the pandemic, registered the <schwabfinancialcare.com> domain in February 2021. Using the “Schwab Financial Care” name, he used his website to allow his customers to apply online. Charles Schwab disputed that the domain had ever been used to provide any services, but asserted that “even if Respondent actually provides financial services, such services would be closely related to those offered by Complainant and therefore competitive and infringing.”
To establish a UDRP claim, a complainant must establish that:
If a respondent can prove that it has been commonly known by the domain name or used it in connection with a bona fide offering of goods or services, rights or legitimate interests may be established.
The three-person panel did not opine as to whether Simon Schwab’s use of the domain infringed Charles Schwab’s trademarks, finding the question beyond the scope of the proceeding. The majority acknowledged that the use of “financial” in the domain might suggest some sort of connection to Charles Schwab, but found that Simon Schwab had not actively contributed to any confusion, and that it was “far from clear” that the services offered competed directly with Charles Schwab’s. The majority similarly credited Simon Schwab’s denial that he registered or used the domain with any intent to target Charles Schwab or its marks. Accordingly, the panelists denied the complaint.
Moreover, the majority found that Charles Schwab had committed reverse domain name hijacking (“RDNH”). Because Charles Schwab initiated the complaint knowing that the domain registrant’s last name was “Schwab,” it should have known it could not prove all UDRP elements. The majority was also concerned with what it called a “lack of candor” in the complaint. Specifically, the complaint included no screenshots of the infringing website, though Charles Schwab had accessed it, and further claimed it was inactive based solely on having received a delivery failure notification after attempting to send a message to the website email address.
The dissenting panelist, on the other hand, found Simon Schwab had failed to produce evidence of any legal entity operating as “Schwab Financial Care,” or that he had ever engaged in any bona fide use of the domain since registering it. The panelist noted: “Where information is likely to be within the exclusive knowledge and control of one party, it is appropriate for the Panel to draw an adverse inference from its absence.” This panelist further argued that Simon Schwab knew of Charles Schwab’s famous mark, registered a domain name combining the mark with a generic term for Charles Schwab’s industry, and used it for a website purporting to offer services related to that industry. Believing Simon Schwab registered the domain with the intent to target and exploit confusion with Charles Schwab, this panelist, unsurprisingly, also dissented from the finding of RDNH.
The case is Charles Schwab & Co., Inc. v. Simon Schwab, Case No. FA2210002017845
Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law
April 27, 2023
Cambridge
Webinar
April 25, 2023
Webinar
European IP Blog
The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO
March 24, 2023
Conference
March 24, 2023
Taipei
INCONTESTABLE® Blog
March 22, 2023
Panel Discussion
Women’s History Month Celebration - Reflections on 50 Years of Title IX in Athletics and Beyond
March 22, 2023
Hybrid
Conference
Best Practices in Intellectual Property Conference – IP in the AI Era: Impact and Challenges
March 20-21, 2023
Tel Aviv
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
The Finnegan UPC Hub is a one-stop shop for our insights related to the Unified Patent Court (UPC).